SGN-B6A
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Integrin
Related Pathways
Cytoskeletal Signaling, Antibody-drug Conjugate/ADC Related
Bioactivity
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog